Sanico, Fe .
HRN: 27-17-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/24/2025
05/31/2025
IV
1.5g
Q8hr
Cellulitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines